Thanks a bunch, NICE. Today comes announcement that NICE are to impose massive fees to approve drugs. This will hit new cancer treatments hard, especially for those with rarer cancers, where not so many patients will mean less profit for developers. NICE charges will range from £99,000 to a whopping £282,000 – so wonder how many of us will find that a drug which helped us when on a clinical trial, won’t be approved for general treatment?

This came out on a Sunday. What’s that they said about “a good day to bury bad news?”

Share This